Share of AI in drug discovery investors worldwide by region 2023

As of Q1 2023, there were approximately 1,900 investors involved in drug discovery with artificial intelligence (AI). More than 55 percent of all these companies originated from the United States. The European Union was ranked second with around 12 percent of these investors located within its member states.

截至2023年第一季度，约有1900名投资者参与人工智能（AI）驱动的药物发现领域。其中，超过55%的公司源自美国。欧洲联盟位列第二，约12%的投资者位于其成员国境内。